Literature DB >> 9605434

Modulation of ceramide-activated protein phosphatase 2A activity by low molecular weight aromatic compounds.

L M Leoni1, H C Shih, L Deng, C Tuey, G Walter, D A Carson, H B Cottam.   

Abstract

Protein phosphatase 2A (PP2A) is one of the most important and abundant serine/threonine phosphatases in mammalian tissues and plays a role in gene expression, cell division, and signal transduction. PP2A is activated by ceramide, which is produced by the hydrolysis of membrane sphingomyelin in response to a variety of stress-related stimuli. To further study the role of ceramide-mediated signal transduction in cellular processes such as senescence and apoptosis, we designed and synthesized a series of low molecular weight aromatic compounds, mainly of the isoquinolone and tetralone classes, and evaluated their ability to inhibit enzymes known to be activated by ceramide. Those enzymes studied were ceramide-activated protein kinase, protein kinase C zeta and PP2A. Of these, only PP2A was found to be inhibited. A few of the compounds inhibited both ceramide-activated as well as basal PP2A activity. In addition, several of the compounds activated PP2A by up to 300% above basal enzyme activity, but only in the presence of ceramide. Thus, modulation (both inhibition and activation) of the catatylic activity of ceramide-activated PP2A is demonstrated by certain low molecular weight aromatic compounds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605434     DOI: 10.1016/s0006-2952(97)00685-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Protein phosphatase 1α mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase.

Authors:  Daniel Canals; Patrick Roddy; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

Review 2.  Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.

Authors:  Michael Voronkov; Steven P Braithwaite; Jeffry B Stock
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

3.  Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA.

Authors:  Zhaiyi Zhang; Olga Kelemen; Maria A van Santen; Sharon M Yelton; Alison E Wendlandt; Vitaliy M Sviripa; Mathieu Bollen; Monique Beullens; Henning Urlaub; Reinhard Lührmann; David S Watt; Stefan Stamm
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

4.  Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.

Authors:  Gauri A Patwardhan; Salman B Hosain; David X Liu; Sachin K Khiste; Yunfeng Zhao; Jacek Bielawski; S Michal Jazwinski; Yong-Yu Liu
Journal:  Biochim Biophys Acta       Date:  2014-09-06

5.  Reciprocal regulation of AKT and MAP kinase dictates virus-host cell fusion.

Authors:  Nishi R Sharma; Prashant Mani; Neha Nandwani; Rajakishore Mishra; Ajay Rana; Debi P Sarkar
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.